SCHEMBL3244805

SCHEMBL3244805

COC(=O)COc1ccc(OCc2cc(-c3ccc(C(F)(F)F)cc3)cc(-c3ccc(C(F)(F)F)cc3)c2)cc1C

nearest known ligand 0.81

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 20/20 0.81
PPARA Q07869 5/20 0.81
PPARG P37231 3/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3237429 0.93 PPARD (0.71) PPARDPPARAPPARG
SCHEMBL3241505 0.89 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL13292269 0.88 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL13292306 0.87 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL13292417 0.87 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL13292309 0.87 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL3230861 0.85 PPARD (1.00) PPARDPPARAPPARG
SCHEMBL13292312 0.85 PPARD (0.90) PPARDPPARAPPARG
SCHEMBL13292322 0.85 PPARD (0.90) PPARDPPARAPPARG
SCHEMBL13292311 0.84 PPARD (0.88) PPARDPPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745445-B2 Compounds and compositions as PPAR modulators IRM LLC (BM) 2010-06-29 US disclosed
US-7745445-B2 Compounds and compositions as PPAR modulators IRM LLC (BM) 2010-06-29 US disclosed
US-7745445-B2 Compounds and compositions as PPAR modulators IRM LLC (BM) 2010-06-29 US disclosed
EP-1756062-A4 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2008-01-02 EP disclosed
US-20070259890-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-11-08 US disclosed
US-20070259890-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-11-08 US disclosed
US-20070259890-A1 Compounds and Compositions as Ppar Modulators IRM LLC (BM) 2007-11-08 US disclosed
EP-1756062-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-28 EP disclosed
WO-2005113506-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259890-A1 Compounds and Compositions as Ppar Modulators PPARG, PPARD, PPARA PPARD 2/4885PPARA 3/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.